å·åŽç 㯔åå äžæã®å šèº«æ§è¡ç®¡ç”ã§ã5æ¥ä»¥äžã®é«ç±ã«ãçµèå è¡ã»å£å/ãã¡ãèã»å€åœ¢çºç¹ïŒãšãã«BCGçã®çºèµ€ïŒã»åè¢ã®å€åã»é žéšãªã³ãç¯è «è¹ã®ãã¡å€æ°ãéãªãã®ãç¹åŸŽã§ãã. å·åŽç ã¯ãäž»ã«ä¹³å¹Œå ã®å šèº«ã®è¡ç®¡ã«ççãèµ·ããç æ°ã§ããæ¥æ¬äººå»åž«ããã®ç æ°ãçºèŠããŠãã57幎ãéããŸãããä»ãªãåå ã¯äžæã§ãã.
å·åŽç ïŒããããã³ãããè±: Kawasaki disease, KDïŒã¯ãæ¥æ¬ã®å°å ç§å»ïŒå·åŽå¯äœã«ãã£ãŠ1960幎代ã«çºèŠããããäž»ã«ä¹³å¹Œå ããããçºç±æ§çŸæ£ïŒç æ°ïŒã§ãããçªç¶ã®é«ç±ãæ°æ¥ç¶ããç®ãåã®å è¡ã身äœã®çºç¹ãæè¶³ã®çºèµ€ïŒïŒèµ€ããªãããšïŒãéŠãªã³ãç¯ã®è «è¹ãªã©æ§ã ãªçç¶ãæ¹ãèµ·ãããå°å æ¥æ§ç±æ§ç®èç²èãªã³ãç¯çå矀ïŒè±: MucoCutaneous Lymph-node Syndrome, MCLSïŒãšãèšãããããäžççã«ãå·åŽç (KD)ããšåŒã°ããã®ãäžè¬çã§ããã
ç åã®ç±æ¥ãšçºèŠ
ç åã¯å·åŽå¯äœã«ãã£ãŠçºèŠãããããšã«ç±æ¥ããã
ç¥å¥å·çå·åŽåžãå·åŽå»ç§å€§åŠãªã©äžèšä»¥å€ã®ãå·åŽããç§°ããäºç©ãšã¯é¢ä¿ããªãããã€ãŠå·åŽåžæµ·å²žéšã®å·¥æ¥å°åž¯ã§å€§æ°æ±æã«ããå ¬å®³ïŒå·åŽå ¬å®³ïŒãåé¡åããæ°ç®¡æ¯åæ¯ãå€ãã¿ãããåœæã¯å°åç¹æã®å ¬å®³ç ãšèª€è§£ãããäŸãå€ãã£ãã
1961å¹ŽïŒæå36幎ïŒãæ¥æ¬èµ€åå瀟äžå€®ç é¢ïŒåŸã®æ¥æ¬èµ€åå瀟å»çã»ã³ã¿ãŒïŒã«å€åããŠããå·åŽå¯äœããçºç±åŸã«æãè¶³ã®ç®èãå¥ãããæçç©è³ªãå¹ããªãåäŸãåããŠèšºå¯ãããããã«åæ§ã®çç¶ã®æ£è ã蚺çããããšããã£ããã«ãåŸæ¥ã®çäŸã«åœãŠã¯ãŸããªãæ°ããç æ°ã§ããããšã確信ãããå·åŽã¯1967å¹Žã«æ¥æ¬èªè«æã1974幎ã«è±èªè«æãçºè¡šãåœåã¯äžä»ã®å°å ç§å»ã®å ±åãšãšããåãå ¥ããããªãã£ãããã¢ã¡ãªã«åè¡åœã§åæ§ã®çäŸãåºçŸããããšã§ãæ°ããç æ°ãšããŠèªç¥ãããããã«ãªã£ãã
1978幎ãäžçä¿å¥æ©é¢ïŒWHOïŒã®åœéçŸç åé¡ã«æ²èŒãããã
çç¶
åæã¯æ¥æ§ç±æ§çŸæ£ïŒæ¥æ§æïŒãšããŠå šèº«ã®è¡ç®¡å£ã«ççãèµ·ããå€ãã¯1-2é±éã§çç¶ãæ²»ãŸããã1ã¶æçšåºŠã«é·åŒãããšããããççã匷ãæã¯èãè¶³ã®ä»ãæ ¹ã®è¡ç®¡ã«ç€ãåºæ¥ãå Žåããããå¿èã®è¡ç®¡ã§ã®ççã«ãããå åèã®èµ·å§éšè¿ããšå·Šå åèã®å·Šåäžè¡æãšå·Šåææã®åå²ä»è¿ã«ç€ãåºæ¥ããããæ¥æ§æã®è¡ç®¡çã«ããç€ã®åæ°ã¯ã2幎以å ã«éçž®ïŒãªã°ã¬ãã·ã§ã³ïŒããããå åèç€ãªã©ã®åŸéºçãæ®ãäºãããã
äž»èŠçç¶ã¯ä»¥äžã®6ã€ã§ããã
- 5æ¥ä»¥äžç¶ãåå äžæã®çºç±ïŒãã ãæ²»çã«ãã5æ¥æªæºã§è§£ç±ããå Žåãå«ãïŒ
- äž¡åŽçŒççµèã®å è¡
- åè¢ã®æ«ç«¯ãèµ€ããªãå ãè «ããïŒæè¶³ã®ç¡¬æ§æµ®è «ãèæ§èœå±ïŒ
- ç®èã®äžå®åçºç¹
- å£åãèµ€ãçããããã¡ãèïŒïŒèãçã£èµ€ã«ãªãïŒãå£è åœé ç²èã®ã³ãŸãæ§çºèµ€ïŒâ»ãã³ãŸãæ§ããšã¯ç å€ãæ¯èŒçåçã«åºãã£ãŠããç¶æ ã§ããããšãæå³ããå»åŠçšèªïŒ
- æçæ§ã®éåè¿æ§é žéšãªã³ãç¯è «è¹
以äž6ã€ã®äž»èŠçç¶ã®ãã¡5ã€ä»¥äžãæºãããã®ãæ¬çãšèšºæãããã5ã€ã«æºããªãéå žåäŸãå€ããçºç±ãçºèµ€ããªã³ãç¯è «è¹ãªã©ã¯ä¹³å¹Œå æã®ãŠã€ã«ã¹ææçã§ã極äžè¬çã«èªããçç¶ã§ããã確å®èšºæã«ã¯å°é£ã䌎ããäž»èŠçç¶ã«ã¯å«ãŸããŠããªãããä¹Ÿç¬æ§ç®ç¹ãéº»çºæ§ã€ã¬ãŠã¹ãäœã¢ã«ããã³è¡çãBCGæ¥çš®éšäœã®çºèµ€ã»çç®åœ¢æãªã©ã¯çæãã¹ãæèŠãšãããã
ç«åŠ
ç¹åŸŽ
æ¬§ç±³ã«æ¯ã¹ããšæ¥æ¬ãã¯ãããšããã¢ãžã¢ã®åœã ã«å€ãïŒæ¥æ¬ãäžè¯äººæ°å ±ååœã倧鿰åœãªã©ïŒãç·å¥³æ¯ã¯å¥³å ãããç·å ã«å€ãåŸåãããã奜çºå¹Žéœ¢ã¯4æ³ä»¥äžã§ç¹ã«1æ³ååŸã«å€ããå åèåŸ 8mm以äžïŒéåžž 2mm以äžïŒãçŽ0.5%çºçããæ»äº¡çã¯çŽ 0.05%çšåºŠã幎霢ã«ããçç¶ã¯ç°ãªãã
æ£è æ°
æ¥æ¬ã§ã¯ã1980幎代åŸåãã1990幎代ã«ãããŠå¹Žéããã6,000人ãçºçããŠããã1999幎ã¯çŽ7,000人ã2000幎ã«ã¯8,000人ãšå¢å åŸåã«ãããæ¥æ¬ã§ã¯1982幎ã«16,000人ã1986幎ã«13,000äººã®æµè¡ããã£ãã2000幎以éãæ£è ã®çºçã¯ç¶ãã2004幎ã«ã¯æ£è æ°10,000人ãè¶ ãã2008å¹Žã®æ£è æ°ã¯11,756人ãå ±åãããŠããããŸãã2008幎ã¯ã10äžäººåœããã®çœ¹æ£ç(0-4æ³å )ãäžæåŸåã§ã218.6人ãšå²äžæé«ãèšé²ããŠããã2018幎ã¯çŽ1äž7000人ãéå»50幎éã§ãæ£è æ°ãå¢ãããæµè¡ãæã床ã èŠãããã
åå
å·åŽç ã®ç å ã¯äžæã§ãææçãªã®ãèªå·±å ç«çŸæ£ãªã®ãã¯ãã¯ã£ããç¹å®ãããŠããããææç説ãã¹ãŒããŒæå説ãèªå·±æå説ãRNAãŠã€ã«ã¹èª¬ãªã©ãæ§ã ãªä»®èª¬ãããããã çºç ã¯å€ãšå¬ã«å€ããå°åæµè¡æ§ãããããšãããäœããã®ææãåŒãéãšãªã£ãŠèµ·ããå¯èœæ§ã瀺åãããŠããã
- 1979幎ãã«ã³ãžã
- 1990幎ãA矀溶é£èã
- 2005幎ãä»®æ§çµæ žèã«ããèè¡çã®å¹Œå æ£è ãå·åŽç é¡äŒŒçç¶ãåããæç𮿧è¡ç®¡å ååº(DIC)ãå䜵ããã
- 2009幎ïŒé 倩å 倧åŠã®ã°ã«ãŒããæ£è ã®äœå ã§å€§éã«å¢ãããããŠçèãæ¡¿èãšãã£ãè€æ°ã®çްèã®ææã«ãã£ãŠåŒãèµ·ããããå¯èœæ§ãé«ããšããç ç©¶çµæãçºè¡šãããããã®çްèãæããæèè¬ïŒSTåå€ïŒãæäžããããšã§ãçç¶ãå埩ããçäŸãåŸãããçµæãçºè¡šããã
- 2011幎ïŒçäŸæ°ã®å€åãšãäžå€®ã¢ãžã¢ã§çºçããŠæ±æ¹ã«ç§»åããå倪平æŽã暪æãããžã§ããæ°æµã®åŸªç°ã®åŒ·åŒ±ãã䌌ãå€åã瀺ãããšãæãããšãªã£ãã
- 2014幎ïŒåœéç ç©¶ããŒã ã«ãã£ãŠãäžåœæ±åéšããã®é¢šãé¢äžããŠãããšããç ç©¶ææããŸãšããããããã®é¢šã«ã¯ã«ã³ãžãé¡ãå€ãå«ãŸããŠããäºã倿ããŠããã
- 2014幎ãåœéç ç©¶ããŒã ã«ãã£ãŠãäžåœåæ±éšã®ç©åå°åž¯ããæ¥ã颚ã«ä¹ã£ãŠéã°ããæ¯çŽ ããæ¥æ¬ã§å·åŽç ã®åå ã«ãªã£ãŠããããšã®æšå®ãçºè¡šããããäžåœã§è¡ãããèŸ²æ¥æ¹é©ã§èŸ²æ¥çç£ãé«ãŸã£ãææãšå·åŽç ã®æµè¡ããŒã¯ãåèŽããŠãããšå€æãå ·äœçã«èšããšãèªæ²»å»ç§å€§åŠå ¬è¡è¡çåŠæå®€ã®ãå·åŽç å šåœèª¿æ»ããã¿ãå·åŽç ç«åŠã®ç¹åŸŽãšãã®å€é·ãã«ãã眹æ£çæšç§»ã°ã©ãã«ã¯éå»3åã®å šåœèŠæš¡ã®å·åŽç æµè¡ã®ããŒã¯ïŒ1979幎ã1982幎ã1986幎ïŒãçŸããŠãããïŒã°ã©ãã¯åºå žæ²èŒã®ãã®ãåç §ã®ããšïŒããã®é ã«äžåœã®èŸ²æã§äœãèµ·ããã調ã¹ããšã1979幎ã«ã¯äžåœæ¿åºã蟲ç£ç©è²·ä»äŸ¡æ Œã18幎ã¶ãã«å€§å¹ ã«åŒãäžããçç£åºæ¿çãåããå·åŽç ã®æã倧ããªããŒã¯ã®1982幎ã®å æ¥ã«ã¯ãåå¥èŸ²å®¶ãžã®è«è² å¶ããèªããäžåœå ±ç£å äžå€®ã®ææžãçºè¡šãããéå£å¶èŸ²ã®äººæ°å ¬ç€Ÿå¶åºŠãäžæ°ã«è§£äœã3çªç®ã®ããŒã¯ã®1986幎ã«ãããŠã蟲ç£ç©ãšå¯ç£ç©ã®çµ±äžè²·ä»ããšå²åœè²·ä»ãå¶åºŠå»æ¢ããªã©èŸ²æ¥çç£ã®èªç±åãç¶ã ãšæã¡åºãããããã®åŸãå·åŽç ã¯ããŒã¯ç¶ã®ïŒãšãã£ãïŒå€åã¯èŠãããªããªããã®ã®ãå°å 人å£10äžäººåœãã眹æ£çã¯å³è©äžããã«é«ãŸã£ãŠéå»ã®ããŒã¯ããããè¶ããŠããŸããããªæ²æšãªç¶æ³ã«ãªã£ããããã®ææãäžåœå ±ç£å ã2004幎ãã2008幎ã«ãããŠåã³èŸ²æ¥åºæ¿çãæ¯å¹Žæã¡åºãã蟲æ°åå ¥å¢å ä¿é²ã蟲æ¥ã€ã³ãã©æŽåãªã©ã§èŸ²æã«èŸ²æ¥çç£ãåŒã³æ»ããŠããã®ã§ãããå·åŽç ã®æµè¡æšç§»ã¯äžåœã®èŸ²æ¥çç£ãšãªã³ã¯ããŠããããšèããŠãããããªã®ã§ãããç ç©¶ã®çé èè ã§ãã¹ãã€ã³ã®ãã«ã»ããã«ããã«ã¿ããã¢æ°åç§åŠç ç©¶æã®æ°åç§åŠè ãã¶ããšã«ã»ãããŒïŒXavier RodoïŒã¯ããããç åãšãªãç²åã®çæãã蟲è¬ãŸãã¯ååŠè¥æã«ãããã®ãªã®ãæ£ç¢ºã«çªãæ¢ãããããããçŠç¹ãçµã£ã調æ»ãå¿ èŠã«ãªãã ããããšèšãããïŒäžåœã®ïŒèŸ²æ¥ããã®ç æ°ã«éèŠãªé¢ä¿ãæã€ããšã¯ééããªãããšã¶ããšã«ã»ãããŒã¯è¿°ã¹ãã
- 2016幎ïŒçååŠç ç©¶æã®ã°ã«ãŒãã¯ãå·åŽç ãžã®çœ¹æ£çãšé¢é£ããããã€ãã®äžå¡©åºå€åãçºèŠããŠããã2016幎ã«ã¯ããããã®äžå¡©åºå€åã®äžã§ããç¹ã«æ¥æ¬äººã«é«é »åºŠã§èŠããããã®ãçºèŠãããŠããã
以äžã®ãããªææãäœããã®ãã£ããã«ãããå šèº«ã®è¡ç®¡ãäžå°åèãžã®èªå·±å ç«ãèªçºããããç ççµç¹äžã¯è¡ç®¡å£ã«ã奜äžçãããã¯ããã¡ãŒãžããªã³ãçãèªããããããçç现èãè¡ç®¡å£ãç Žå£ããããšã«ãããå åèã®æ¡åŒµãåè¢æ«ç«¯ã®æµ®è «ãåŒãèµ·ãããããšèããããŠããã
æ°åã³ãããŠã€ã«ã¹ææçãšã®é¢é£
2020幎ã«ã¯ãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã«çœ¹æ£ããäžéšã®åäŸããå·åŽç ã«äŒŒãçç¶ãåããŠãããšã®å ±åãæ¬§ç±³ã§çžæ¬¡ããæ±äº¬éœç«å°å ç·åå»çã»ã³ã¿ãŒïŒæ±äº¬éœåºäžåžïŒã§3æäžæ¬ãæ°åã³ãããŠã€ã«ã¹ã«ææããå ¥é¢ãã1æ³ç·å ããã®åŸãå šèº«ã®è¡ç®¡ã«ççãèµ·ããå·åŽç ãšèšºæãããã
äºé²
åå ãã¯ã£ããããŠããªããããæ±ºå®çãªäºé²æ³ãæ€æ»æ³ã¯ç¢ºç«ãããŠããªãã
æ²»ç
å·åŽç æ²»çã®ç®çã¯ãæ¥æ§æã®ççåå¿ãå¯èœãªéãæ©æã«çµæ¯ãããããšã§ãå åèç€ã®åœ¢æãäºé²ããããšã§ãããåææ²»çãšããŠã¯å ç«ã°ãããªã³ãšãã¬ãããŸãã³ãã¢ã¹ããªã³ã䜵çšãããããã®äœµçšçæ³ã«ãã48æé以å ã«è§£ç±ããªãããŸãã¯2é±é以å ã«åçãèŠãããå Žåãäžå¿äŸãšããã
äžå¿äŸã«ã¯ãå ç«ã°ãããªã³ãšã·ã¯ãã¹ããªã³ãããã¯ã€ã³ããªãã·ããã®äœµçšæäžãè¡ãããã¹ããã€ããã«ã¹çæ³ãæçšãªäŸãå ±åãããŠããããŸãå åèãæ¡åŒµãæ¥ããŠããªãããå¿ãšã³ãŒã«ãããã©ããŒããå¿ èŠããããå åèç å€ã奜çºãã第10ç æ¥ã§è¡ããç°åžžãèªããããªãå Žåã«ã¯çºç åŸ6é±ã§åæ€ããïŒå®éã¯åæœèšã«ããå¿ãšã³ãŒãè¡ãææã¯ãŸã¡ãŸã¡ãšæãããïŒãå åèç å€ãèªããããªãå Žåããã®æç¹ã§ã¢ã¹ããªã³ãäžæ¢ããã
5æ¥ä»¥äžæç¶ããçºç±ã蚺æåºæºã®1ã€ãšãªã£ãŠãããã®ã®ãä»ã®èšºæé ç®ããæããã«å·åŽç ãšå»åž«ã«ãã£ãŠèšºæãããå Žåã«ã¯ãçºç±5æ¥ãŸã§æ²»çéå§ãåŸ ã€å¿ èŠã¯ãªããé ããšããçºç7æ¥ä»¥å ã«æ²»çéå§ããããšãæãŸãããšãããã
äºåŸãšåŸéºç
å åèé害ããªãå ŽåãæäººåŸã®é éæã§ã®å¿çŸæ£ãªã¹ã¯ã®ã³ã³ãããŒã«ã«çæããå¿ èŠããããçºçãã1-3é±éåŸãããã«10-20%ã®é »åºŠã§å åèã«åèç€ãèªãããããŸãã«å¿çæ¢å¡ã«ããçªç¶æ»ã«è³ãããšããããå åèç€ã®çŽåæ°ã¯ã1-2幎çšåºŠã§éçž®ïŒãªã°ã¬ãã·ã§ã³ïŒããããæ®ãã®åæ°ã¯éçž®ããæ®ããå åèéå®³ãæ²»ã£ãå Žåã§ããå åèã®ç¶æ ã¯æé·ãšå ±ã«å€åãå¿èé害ã®ãªã¹ã¯ãé«ããªããåŸã£ãŠã宿çãªæ€æ»ãå¿ èŠã«ãªãã巚倧ãªç€ãçºçããæ£è ã§ã¯ã15幎ã§çŽ70%ã¯å åèã«ççªãéå¡ãèŠã€ãããã60%çšåºŠã¯ç¡çç¶ã§ç¡çåæ§å¿çæ¢å¡ãšåŒã°ããã
å ç«ã°ãããªã³éæ³šçæ³ã«ãã£ãŠå åèç€ã®é »åºŠãäœäžããŠããããšãæããã«ãªã£ãŠããäžæ¹ãäŸç¶ãšããŠå·šå€§å ç¶åèç€ã®é »åºŠã«ã¯å€§ããªå€åããªããæªã ã«ããæå¹ãªæ²»çæ³ã«åããŠç ç©¶ãé²ããããŠããã
å åèé害ïŒççªïŒã«ããè¡è¡ãååã«ç¢ºä¿ãããªãïŒå¿çèè¡ïŒå Žåã¯ãè¡è¡å建è¡ïŒå€ç§æè¡ïŒã«ããæ²»çãè¡ããå ·äœçã«ã¯ãã«ããŒãã«ã«ããçµç®çå åè圢æè¡(PTCA)ãšå åèãã€ãã¹è¡(CABG)ã§ãçºçåŸ2幎以å ã«è¡ããšæ²»ç广ãé«ããäžæ¹ãçºçãã10æ°å¹Žçµéããè¡ç®¡å£ãåãè¡ç®¡å éšã§ç³ç°åããŠããå Žåã¯ãããŒã¿ãã¬ãŒã¿ãŒã«ããå å£ãåããããããã«ããŒãã«ãããŒã¿ãã¬ãŒã¿ãŒã§æ²»çã§ã¯åã³ççªãé²è¡ããããšããããæ ¹æ¬æ²»çã¯å åèãã€ãã¹æè¡ã§ãå¿èãžã®è¡è¡ãå埩ãããšéåå¶éã¯ç¡ããªãã
å¿çèè¡ããªãå Žåã¯éåå¶éãè¡ãå¿ èŠã¯ãªãã
èæ³š
åèæç®
- äžæµŠå€§ãå·åŽç = Kawasaki Disease : å¢ãç¶ããè¬ã®å°å çŸæ£ãåŒæå ã2019幎11æãISBN 978-4-335-76020-4ãÂ
å€éšãªã³ã¯
- æ¥æ¬å·åŽç ç ç©¶ã»ã³ã¿ãŒ
- æ¥æ¬å·åŽç
åŠäŒ
- å·åŽç æ¥æ§ææ²»çã®ã¬ã€ãã©ã€ã³ (PDF, 219 KiB)
- å·åŽç
éºäŒã³ã³ãœãŒã·ã¢ã
- Z-Score Project
- å·åŽç å¿èè¡ç®¡åŸéºçã®èšºæãšæ²»çã«é¢ããã¬ã€ãã©ã€ã³ 2020幎æ¹èšç – æ¥æ¬åŸªç°åšåŠäŒ
- å·åŽç ã®åäŸããã€èŠªã®äŒ
- å·åŽç – åœç«ç ç©¶éçºæ³äººåœç«æè²å»çç ç©¶ã»ã³ã¿ãŒ
- å·åŽç ãšå ç«ã°ãããªã³çæ³ã«ã€ã㊠(PDF, 1.0 MiB) – æ¥æ¬å·åŽç åŠäŒã第1çïŒ2006幎10æ13æ¥çºè¡ïŒã2019幎11æ17æ¥é²èЧ
- å·åŽç – MSDããã¥ã¢ã«
å·åŽç ã®çè·èšç»ïœç æ ççãã¢ã»ã¹ã¡ã³ãã«ã€ããŠã解説 ããŒã¹ããïœå°å çè·ã®åŠæ ¡
[B!] ç¥ã£ãŠãããã!å±éºãªåã©ãã®ç æ° ãå·åŽç ã ãããã®å¥åº·
å·åŽç
ãåœè©Šå¯Ÿçãå·åŽç ãšã¯ïŒ6倧çç¶ã»æ²»çã»çè·ã®ãã€ã³ãããããããã解説ãå°å çè·ã ãšããŽãŒå°å çè·ãŒã
乳幌å ããããå·åŽç ã æãã§çºçãªã¹ã¯äžæ æ±äº¬ç§åŠå€§ããŒã æ¯æ¥æ°è
æç§å·åŽç ïŒ
ãåè²ãŠäžä»£ã«ç¥ã£ãŠã»ãããå·åŽç ãšããåã©ãã®ç æ°ã ãããããããã¯å·åŽç æ£è ã®äžã§ããéçã§ãã 0/2 ãmoroïŒ åè¡æ¬çºå£²äžã®æŒ«ç»
å·åŽç .ppt_wordææ¡£åšçº¿é 读äžäžèœœ_æ å¿§ææ¡£
å·åŽç ã£ãŠã©ããªç æ°ïŒãŒèŠªãç¥ã£ãŠããã¹ããã€ã³ããå°å ç§å°éå»ã解説 ããDrã®å°å ç§ããŒã
å®ç¿ã§äœ¿ããïŒå·åŽç æ£è ã®ã¢ã»ã¹ã¡ã³ãå®å šã¬ã€ãïœçè·åž«å€«å©Šâïžãªã
å·åŽç ã®6ã€ã®çç¶ã®ã€ã©ã¹ãðšãããªãŒçŽ æãïœçè·roo![ã«ã³ãŽã«ãŒ]
ãåœè©Šå¯Ÿçãå·åŽç ãšã¯ïŒ6倧çç¶ã»æ²»çã»çè·ã®ãã€ã³ãããããããã解説ãå°å çè·ã ãšããŽãŒå°å çè·ãŒã
ãé¢ä¹ ãå·åŽç Kawasaki DiseaseïŒäžè±åå¹ïŒ_åå©åå©_bilibili
ãåœè©Šå¯Ÿçãå·åŽç ãšã¯ïŒ6倧çç¶ã»æ²»çã»çè·ã®ãã€ã³ãããããããã解説ãå°å çè·ã ãšããŽãŒå°å çè·ãŒã
å·åŽç ã«ã€ã㊠åèåžç«æµ·æµç é¢
ãåœè©Šå¯Ÿçãå·åŽç ãšã¯ïŒ6倧çç¶ã»æ²»çã»çè·ã®ãã€ã³ãããããããã解説ãå°å çè·ã ãšããŽãŒå°å çè·ãŒã
ãåœè©Šå¯Ÿçãå·åŽç ãšã¯ïŒ6倧çç¶ã»æ²»çã»çè·ã®ãã€ã³ãããããããã解説ãå°å çè·ã ãšããŽãŒå°å çè·ãŒã
å·åŽç çç¶èŠãæ¹ _ å·åŽç ã®äž»èŠçç¶ GJDDRL
å·åŽç (ããããã³ãã)ãšã¯ æžçäŒ
å·åŽç çµé衚 å·åŽç ã¬ã€ãã©ã€ã³ HOZHDX
å·åŽç ãšã¯ å šèº«ã®è¡ç®¡ã®ççã«ãã£ãŠæ§ã ãªçç¶ãåºçŸããã乳幌å ã«ç¹æã®ç æ°ã§ãã2025幎æç¹ã§ã®ææ°ã®æ¥æ¬ã®çµ±èšã§ã¯ã6æ³æªæºã§ã®çºçãå·åŽç æ£è å šäœã®çŽ93%ãå ããŠããã5æ³æªæºã®ãã©ã1000人ã«å¯ŸããŠçŽ2.5人ã®é »åºŠã幎éã§ã¯çŽ1.2äžäººãå·åŽç ãçºçããŠããŸãããã®ç æ°ã®åå .. Vol.9 å ¬éïŒä»€å7幎9æ å·åŽç ã®çç¶ãç¥ã£ãŠããã æ±äº¬éœç«å€æ©åéšå°åç é¢ å¯é¢é· äžæµŠ 倧